Home
About
Overview
Sharing Data
ORCID
Help
History (59)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Azhar, Naila
VEGF/Neuropilin Signaling in Cancer Stem Cells.
NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection.
TP53 mutations in head and neck cancer.
See All 59 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TP53 mutations in head and neck cancer.
Nathan CA, Khandelwal AR, Wolf GT, Rodrigo JP, M?kitie AA, Saba NF, Forastiere AA, Bradford CR, Ferlito A. TP53 mutations in head and neck cancer. Mol Carcinog. 2022 04; 61(4):385-391.
View in:
PubMed
subject areas
Animals
Carcinoma, Squamous Cell
Head and Neck Neoplasms
Humans
Mutation
Papillomaviridae
Papillomavirus Infections
Tumor Suppressor Protein p53
authors with profiles
Greg Wolf